1 |
Chun, L. J., Tong, M. J., Busuttil, R. W. and Hiatt, J. R. (2009) Acetaminophen hepatotoxicity and acute liver failure. J. Clin. Gastroenterol. 43, 342-349.
DOI
|
2 |
Etheridge, A., Lee, I., Hood, L., Galas, D. and Wang, K. (2011) Extracellular microRNA: a new source of biomarkers. Mutat. Res. 717, 85-90.
DOI
|
3 |
Faraoni, I., Antonetti, F. R., Cardone, J. and Bonmassar, E. (2009) miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 1792, 497-505.
DOI
|
4 |
Guay, C. and Regazzi, R. (2013) Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat. Rev. Endocrinol. 9, 513-521.
DOI
|
5 |
Hinson, J. A., Roberts, D. W. and James, L. P. (2010) Mechanisms of acetaminophen-induced liver necrosis. Handb. Exp. Pharmacol. (196), 369-405.
|
6 |
Hu, G., Drescher, K. M. and Chen, X. M. (2012) Exosomal miRNAs: biological properties and therapeutic potential. Front. Genet. 3, 56.
|
7 |
Huang, Y., Liu, Y., Li, L., Su, B., Yang, L., Fan, W., Yin, Q., Chen, L., Cui, T., Zhang, J., Lu, Y., Cheng, J., Fu, P. and Liu, F. (2014) Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC Nephrol. 15, 142.
DOI
|
8 |
Ichii, O., Otsuka, S., Sasaki, N., Namiki, Y., Hashimoto, Y. and Kon, Y. (2012) Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int. 81, 280-292.
DOI
|
9 |
John, K., Hadem, J., Krech, T., Wahl, K., Manns, M. P., Dooley, S., Batkai, S., Thum, T., Schulze-Osthoff, K. and Bantel, H. (2014) MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology 60, 1346-1355.
DOI
|
10 |
Kaplowitz, N. (2005) Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 4, 489-499.
DOI
|
11 |
Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E. and Ambros, V. (2004) Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5, R13.
DOI
|
12 |
Nonaka, I., Takagi, A., Ishiura, S., Nakase, H. and Sugita, H. (1983) Pathophysiology of muscle fiber necrosis induced by bupivacaine hydrochloride (Marcaine). Acta Neuropathol. 60, 167-174.
DOI
|
13 |
Ohno, S., Ishikawa, A. and Kuroda, M. (2013) Roles of exosomes and microvesicles in disease pathogenesis. Adv. Drug Deliv. Rev. 65, 398-401.
DOI
|
14 |
Sanchez-Gonzalez, P. D., Lopez-Hernandez, F. J., Perez-Barriocanal, F., Morales, A. I. and Lopez-Novoa, J. M. (2011) Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrol. Dial. Transplant. 26, 3484-3495.
DOI
|
15 |
Starkey Lewis, P. J., Dear, J., Platt, V., Simpson, K. J., Craig, D. G., Antoine, D. J., French, N. S., Dhaun, N., Webb, D. J., Costello, E. M., Neoptolemos, J. P., Moggs, J., Goldring, C. E. and Park, B. K. (2011) Circulating microRNAs as potential markers of human druginduced liver injury. Hepatology 54, 1767-1776.
DOI
|
16 |
Taganov, K. D., Boldin, M. P., Chang, K. J. and Baltimore, D. (2006) NF- -dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103, 12481-12486.
DOI
|
17 |
Toivonen, J. M., Manzano, R., Olivan, S., Zaragoza, P., Garcia-Redondo, A. and Osta, R. (2014) MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE 9, e89065.
DOI
|
18 |
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E. and Galas, D. J. (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U.S.A. 106, 4402-4407.
DOI
|
19 |
Turchinovich, A., Weiz, L., Langheinz, A. and Burwinkel, B. (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233.
DOI
|
20 |
Wang, G., Kwan, B. C., Lai, F. M., Chow, K. M., Li, P. K. and Szeto, C. C. (2011) Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis. Markers 30, 171-179.
DOI
|
21 |
Ward, J., Kanchagar, C., Veksler-Lublinsky, I., Lee, R. C., McGill, M. R., Jaeschke, H., Curry, S. C. and Ambros, V. R. (2014) Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis. Proc. Natl. Acad. Sci. U.S.A. 111, 12169-12174.
DOI
|
22 |
Williams, A. H., Valdez, G., Moresi, V., Qi, X., McAnally, J., Elliott, J. L., Bassel-Duby, R., Sanes, J. R. and Olson, E. N. (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554.
DOI
|
23 |
Yu, D. C., Li, Q. G., Ding, X. W. and Ding, Y. T. (2011) Circulating microRNAs: potential biomarkers for cancer. Int. J. Mol. Sci. 12, 2055-2063.
DOI
|
24 |
Zhang, Y., Jia, Y., Zheng, R., Guo, Y., Wang, Y., Guo, H., Fei, M. and Sun, S. (2010) Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin. Chem. 56, 1830-1838.
DOI
|
25 |
Liu, N., Williams, A. H., Maxeiner, J. M., Bezprozvannaya, S., Shelton, J. M., Richardson, J. A., Bassel-Duby, R. and Olson, E. N. (2012) microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest. 122, 2054-2065.
DOI
|
26 |
Ason, B., Darnell, D. K., Wittbrodt, B., Berezikov, E., Kloosterman, W. P., Wittbrodt, J., Antin, P. B. and Plasterk, R. H. (2006) Differences in vertebrate microRNA expression. Proc. Natl. Acad. Sci. U.S.A. 103, 14385-14389.
DOI
|
27 |
Bala, S., Petrasek, J., Mundkur, S., Catalano, D., Levin, I., Ward, J., Alao, H., Kodys, K. and Szabo, G. (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56, 1946-1957.
DOI
|
28 |
Boots, A. W., Haenen, G. R. and Bast, A. (2008) Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585, 325-337.
DOI
|
29 |
Cho, Y. E., Singh, T. S., Lee, H. C., Moon, P. G., Lee, J. E., Lee, M. H., Choi, E. C., Chen, Y. J., Kim, S. H. and Baek, M. C. (2012) In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach. Mol. Cell Proteomics 11, M111.010884.
|
30 |
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W. and Tuschl, T. (2002) Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739.
|
31 |
Miller, R. P., Tadagavadi, R. K., Ramesh, G. and Reeves, W. B. (2010) Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2, 2490-2518.
DOI
|
32 |
Mizuno, H., Nakamura, A., Aoki, Y., Ito, N., Kishi, S., Yamamoto, K., Sekiguchi, M., Takeda, S. and Hashido, K. (2011) Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS ONE 6, e18388.
DOI
|
33 |
Morales, A. I., Vicente-Sanchez, C., Jerkic, M., Santiago, J. M., Sanchez-Gonzalez, P. D., Perez-Barriocanal, F. and Lopez-Novoa, J. M. (2006a) Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats. Toxicol. Appl. Pharmacol. 210, 128-135.
DOI
|
34 |
Morales, A. I., Vicente-Sanchez, C., Sandoval, J. M., Egido, J., Mayoral, P., Arevalo, M. A., Fernandez-Tagarro, M., Lopez-Novoa, J. M. and Perez-Barriocanal, F. (2006b) Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties. Food Chem. Toxicol. 44, 2092-2100.
DOI
|
35 |
Nakasa, T., Ishikawa, M., Shi, M., Shibuya, H., Adachi, N. and Ochi, M. (2010) Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J. Cell. Mol. Med. 14, 2495-2505.
DOI
|